AI-Assisted 4-Week Psychodynamic Therapy and Cognitive Behavioral Therapy Via Smartphone for Social Anxiety: A Randomized Pilot Study (STePS-Ai)
STePS-Ai
Smartphone-Based Treatments for Social Anxiety With Artificial Intelligence Support: A Three-Arm Randomized Controlled Pilot Study Comparing Psychodynamic Therapy, Cognitive Behavioral Therapy, and Waitlist (STePS-Ai)
1 other identifier
interventional
90
1 country
1
Brief Summary
This pilot study compares two 4-week, smartphone-based treatments for social anxiety: one uses a psychodynamic therapy approach and the other uses a cognitive behavioral therapy approach. Both treatments are guided by an AI assistant rather than a human therapist. The AI assistant is programmed to support participants in reflecting on core therapeutic principles, much like a well-informed coach would. Participants are randomly assigned to one of three groups: psychodynamic therapy with AI support, cognitive behavioral therapy with AI support, or a waitlist control. Those in the waitlist group can receive an active treatment after the 4-week waiting period. All participants complete weekly online questionnaires to monitor anxiety and any changes in mood or well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 21, 2025
CompletedFirst Submitted
Initial submission to the registry
May 13, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2025
CompletedFirst Posted
Study publicly available on registry
April 16, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedApril 16, 2026
April 1, 2026
2 months
May 13, 2025
April 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Social Phobia Inventory (SPIN)
The Social Phobia Inventory (SPIN) is a 17-item self-report questionnaire that measures fear, avoidance and physiological symptoms of social anxiety. Each item is rated on a 5-point Likert scale (0 = "not at all" to 4 = "extremely"), yielding a total score range from 0 to 68. Higher scores indicate more severe social anxiety symptoms.
Baseline (pre-randomization), weekly during the 4-week intervention, post-treatment at week 4, and 1-month follow-up
Secondary Outcomes (3)
Liebowitz Social Anxiety Scale Self-Report (LSAS-SR)
Baseline, 4 weeks, and 1 month
Patient Health Questionnaire-9 (PHQ-9)
Baseline, weekly during weeks 1 through 4 (Patient Health Questionnaire-2 short form), 4 weeks (full scale), and 1 month
Generalized Anxiety Disorder-7 (GAD-7)
Baseline, weekly during weeks 1 through 4 (Generalized Anxiety Disorder-2 short form), 4 weeks (full scale), and 1 month
Study Arms (3)
Smartphone-based psychodynamic therapy with AI support
EXPERIMENTALThis arm features a 4-week smartphone-delivered psychodynamic therapy intervention guided by an AI assistant. Participants will access structured treatment modules that emphasize emotional awareness, reduction of avoidance behaviors, and enhancement of affect regulation in social contexts. The AI assistant provides real-time reflection prompts, motivational support, and automated feedback based on the established psychodynamic material, ensuring consistent engagement throughout the treatment period. Weekly assessments monitor symptom changes, with data collected to evaluate the intervention's effectiveness in reducing social anxiety.
Smartphone-based cognitive behavior therapy with AI support
EXPERIMENTALThis arm features a 4-week smartphone-delivered cognitive behavioral therapy (CBT) intervention guided by an AI assistant. Participants will access structured treatment modules that focus on psychoeducation about anxiety, cognitive restructuring to challenge and modify unhelpful thoughts, behavioral exposure techniques, and behavioral experiments to reduce avoidance. The AI assistant provides real-time reflection prompts, task reminders, motivational support, and automated feedback based on established CBT protocols, ensuring consistent engagement throughout the treatment period. Weekly assessments will monitor symptom changes, with data collected to evaluate the intervention's effectiveness in reducing social anxiety.
Waitlist
NO INTERVENTIONThis arm involves a waitlist control condition where participants do not receive an active intervention during the 4-week period. Instead, they complete the same weekly assessments used in the active treatment arms to monitor changes in social anxiety symptoms and overall well-being. After the study period, participants will be offered the option to choose one of the active treatment approaches if desired.
Interventions
This intervention uses an AI-enabled chatbot within a smartphone app to deliver psychotherapy modules. The chatbot guides participants through the modules by providing reflective prompts, motivational support and automated reminders to enhance engagement. All communication is encrypted to protect privacy.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Stockholm university
Stockholm, Stockholm County, 10691, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Per Carlbring, PhD
Stockholm University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 13, 2025
First Posted
April 16, 2026
Study Start
April 21, 2025
Primary Completion
June 21, 2025
Study Completion (Estimated)
July 1, 2026
Last Updated
April 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
- Time Frame
- Anticipated during 2025.
- Access Criteria
- By visiting Figshare or OSF.
The individual participant data (IPD) that will be shared (Figshare or OSF) include de-identified, participant-level data from all phases of the study. Specifically, this dataset will contain (limited) demographic information, screening results, baseline assessments, and all primary and secondary outcome measures as well as some treatment engagement data. Data will be stripped of any identifying information and aggregated where appropriate to ensure confidentiality and compliance with data protection regulations.